Trademark: 98657918
Word
ABILEAP
Status
Pending
Status Code
630
Status Date
Friday, July 19, 2024
Serial Number
98657918
Mark Type
4
Filing Date
Friday, July 19, 2024

Trademark Owner History

Classifications
5 antibody products and molecules acting as immune modulators for scientific and medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories;
1 antibody products and molecules for scientific and medical purposes;
42 antibody profiling for scientific research purposes, for discovery and development of new biotherapeutics; operation of scientific database and website regarding research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development; clinical trials; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] for analyzing molecular and clinical data to develop antibodies against immune targets; analysis in the field of molecular biology; molecular analysis and product optimization for the purpose of pharmaceutical development;

Trademark Events
Jul 19, 2024
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24